Because loss of BRCA2 is associated with susceptibility to breast cancer, we generated two clonal cell lines with stable BRCA2 knockdown in the breast cancer cell line MDA‐MB231to assess synthetic lethality with SIK2 in a relevant cancer type. The gene discussed is BRCA2; the disease is breast carcinoma.